Xellia Pharmaceuticals Aps, based in Denmark, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is BACITRACIN ZINC, STERILE, with a corresponding US DMF Number 28355.
Remarkably, this DMF maintains an Active status since its submission on June 20, 2014, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 07, 2014, and payment made on June 13, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II